PEPFAR Implementing Partner
Home About Us Countries Working With Us Resource Center Jobs Prices & E-Catalog

RESOURCE CENTER

 
Home > Resource Center > Community Contributions

Lessons Learned in Supply Chain Management of HIV & AIDS Commodities
The lessons learned from the USAID | DELIVER PROJECT's experience in designing and implementing HIV and AIDS commodity supply chains and strengthening health system capacity to manage HIV commodities.


Read More!



HELPFUL RESOURCES



Trends


Comprehensive HIV Prevention for People Who Inject Drugs, Revised Guidance
Immediately ahead of the International AIDS Conference in Vienna this week, OGAC issued revised guidance on HIV/AIDS prevention and treatment services for IDUs. This guidance confirms that PEPFAR will consider funding of needle exchange as part of harm reduction strategies and will, as we know, fund the supply of methadone and other oral heroin substitutes.


Lessons Learned in Supply Chain Management of HIV & AIDS Commodities
The lessons learned presented here are The lessons learned from the USAID | DELIVER PROJECT's experience in designing and implementing HIV and AIDS commodity supply chains and strengthening health system capacity to manage HIV commodities.


Continuity and Change: Implementing the Third WHO Medicines Strategy - 2008-2013
This report provides practical guidance to WHO and stakeholders on how the essential medicines concept and WHO’s expertise will be used to promote universal access and patient-centred health care for all. It presents priorities for action by WHO as a guide for future investment and planning decisions, and serves as a user-friendly document for stakeholders.


Fact Sheet: The U.S. Government’s Global Health Initiative
Through the Global Health Initiative (GHI), the United States is investing $63 billion over six years to help partner countries improve health outcomes through strengthened health systems. The initiative has a particular focus on bolstering the health of women and girls, newborns and children by combating infectious diseases and providing quality health services. GHI aims to maximize the sustainable health impact the United States achieves for every dollar invested.


World Health Statistics 2009
World Health Statistics 2009 contains WHO's annual compilation of data from its 193 Member States, and includes a summary of progress towards the health-related Millennium Development Goals and targets. This edition also contains a new section on reported cases of selected infectious diseases.


WHO, UNAIDS and UNICEF report Towards universal access: Scaling up priority HIV/AIDS interventions in the health sector
The close of 2007 marks an important step in the history of the HIV/AIDS epidemic. Nearly 3 million people are now receiving anti-retroviral therapy (ART) in low- and middle-income countries, according to a new report jointly launched today by WHO, UNAIDS and UNICEF.


Using mobile phones in HIV care and prevention
This edition of HIV & AIDS Treatment in Practice explores the potential of mobile phones and presents case studies to illustrate the ways in which mobile phone technology is already being used in HIV treatment and care. HATIP also includes a monthly column focused on advancing the integration of HIV and TB services, exploring the challenges and practical solutions to the implementation of TB/HIV collaborative activities, and improving the diagnosis and treatment of the more difficult-to-manage forms of TB that are common in people with HIV, including smear negative, extrapulmonary and drug resistant TB. This document is from NAM / www.aidsmap.com.


USAID: Assessing Supply Chains for HIV/AIDS Commodities
This paper presents technical guidance for assessing supply chain management (SCM) systems for HIV/AIDS programs in the context of system design, implementation, monitoring, and evaluation.


The Treatment Timebomb
The report describes how by 2030 over 50 million people will need HIV treatment compared to just 9 million who need it today.


The Global Economic Crisis and HIV Prevention and Treatment Programmes: Vulnerabilities and Impact
The global economic crisis threatens recent gains in health and poverty reduction in developing countries. What can be done to avoid negative impacts? This documents presents findings based on information collected in late March 2009 from respondents in 71 countries (in which 3.4 million people are on antiretroviral treatment)


The Deadly World of Fake Drugs
Foreign Policy articles which examines the fake druge industry and what is being done to identify counterfeit medicine.


Living well with HIV/AIDS
A manual from the World Health Organization and Food and Agriculture Organization of the United Nations on nutritional care and support for people living with HIV/AIDS.


PEPFAR


Fact Sheet on Reauthorizing PEPFAR
On July 30, 2008, President George W. Bush signed into law H.R. 5501, the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008. This legislation responds to the President’s call last year to expand the U.S. Government commitment to this successful program for five additional years, from 2009 through 2013.



PEPFAR Annual Report to Congress 2009
Celebrating Life: The U.S. President’s Emergency Plan for AIDS Relief


PEPFAR - HIV AIDS and the US Government's Response: The Power of Partnerships
Overview of PEPFAR goals, countries in where PEPFAR is working, approaches to prevent transmission and strategy for how partnerships can help.


PEPFAR Five Year Strategy
The Five-Year Strategy of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) outlines the high-level direction of the program for its next phase. This strategy reflects lessons learned in the first five years of the program, expands existing commitments around service delivery, and places a heightened emphasis on sustainability.


Collaboration


Power of Partnerships
Fourth Annual Report to Congress on PEPFAR (2008) outlines the role of America's partnerships in the worldwide fight against HIV/AIDS.


Guidelines for Managing the HIV/AIDS Supply Chain
The Guidelines for Managing the HIV/AIDS Supply Chain is a set of references for managers working to ensure a continuous supply of quality HIV/AIDS commodities to programs. The Guidelines highlight lessons learned from JSI and DELIVER advisors experience designing, implementing, and improving HIV/AIDS supply chains in resource limited settings.


Policy Guidelines for Collaborative TB and HIV Services for Injecting and Other Drug Users, An Integrated Approach
These guidelines are intended for professionals dealingwith the drug users who have the most problematicpatterns of use and who have the greatest riskof HIV and TB, especially those who inject drugs.


Warehousing and Distribution


Guidelines for Warehousing Health Commodities
Guidelines for Warehousing Health Commodities provides up-to-date information on all aspects of warehousing. The guidelines consist of four sections—human resource, layout planning, racking systems and material handling equipment, and warehouse management system.


Guidelines for the Storage of Essential Medicines and Other Health Commodities
A practical reference for those managing or involved in setting up a storeroom or warehouse. The guide contains written directions and clear illustrations on receiving and arranging commodities; special storage conditions; tracking commodities; maintaining the quality of the products; constructing and designing a medical store; waste management; and resources.


Delivering HIV/AIDS Products to Customers
Lessons Learned in Supply Chain Management. Drawing on examples from interventions in many of the 18 countries mentioned above, this paper illustrates how several unique characteristics of HIV/AIDS programs or commodities affect supply chain management.


Forecasting and Supply Planning


A Practical Approach to Pharmaceutical Policy
Pharmaceuticals are an essential component of health care. But for many people in low- and middle-income countries, access to the medicines they need to prevent or treat severe illnesses is limited. Typical problems are lack of availability, costs that exceed the individual’s purchasing power or lack of competent “agents” – health workers that are well trained to give the correct advice on which medicines to take.


Pipeline User's Guide
A software tool designed to help program managers regularly monitor the status of their product pipelines and product.


Quantification of Health Commodities: HIV Test Kit Companion Guide
The primary focus and purpose of this companion guide is to supplement the general guide on Quantification of Health Commodities: A Guide to Forecasting and Supply Planning for Procurement by describing in detail the specific methodology for forecasting consumption of HIV test kits as a critical step in the overall quantification process.


Guide for Quantifying ARV Drugs
This guide for quantifying ARV drugs draws from the collective experience of DELIVER logistics advisors who have been involved in a range of activities to improve management of the supply chains for HIV/AIDS commodities in several countries that are hardest hit by the epidemic.


Guide for Quantifying HIV Tests
This guide for quantifying HIV tests draws from the collective experience of DELIVER logistics advisors who have been involved in a range of activities to improve management of the supply chains for HIV/AIDS commodities in several countries that are hardest hit by the epidemic. The list of countries includes Ghana, Kenya, Malawi, Mozambique, Nepal, Nigeria, South Africa, Tanzania, Uganda, Ukraine, Zambia, and Zimbabwe.


The Contraceptive Forecasting Handbook
The Contraceptive Forecasting Handbook for Family Planning and HIV/AIDS Prevention Programs is designed as a reference book for forecasting commodity needs for family planning and HIV/AIDS prevention programs.


Antiretroviral (ARV) drugs


WHO Technical Reference Group Report
Recommendations from the Reference Group, Pediatric HIV/ART Care Guideline Group Meeting


NIH Guidelines
Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection


HHS AIDSInfo Guide
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents.


USAID Issue Brief: Delivering a Lifeline: Comprehensive Antiretroviral Therapy Programs
Antiretroviral drugs are just one aspect of a comprehensive HIV/AIDS treatment, care, and support program that includes meeting the medical, psychological, socioeconomic, and legal needs of those affected by the disease. In USAID’s ART programs, the treatment component consists of the use of at least three ARV medications. The objective of the drug component is to suppress HIV replication and slow the progression of HIV disease.


Antiretroviral Treatment of Adult HIV Infection: 2008 Recommendations of the International AIDS Society USA Panel
The availability of new antiretroviral drugs and formulations, including drugs in new classes, and recent data on treatment choices for antiretroviral-naive and -experienced patients warrant an update of the International AIDS Society–USA guidelines for the use of antiretroviral therapy in adult human immunodeficiency virus (HIV) infection.


Laboratory


Lab Logistics Handbook: A Guide to Designing and Managing Laboratory Logistics Systems
This document describes the function and organization of laboratory services and the commodities needed for laboratory services, and it discusses supply chain considerations for management of laboratory commodities.


Laboratory Harmonization 2008
Access resources developed from the Consensus Meeting on Clinical Laboratory Testing Harmonization and Standardization. A reference guide was published and distributed for developing a National Laboratory Strategic Plan, in direct response to a recommendation of the January 2008 "Consensus Meeting on Harmonization and Standardization of Laboratory Tests and Equipment for HIV/AIDS, Tuberculosis and Malaria".


UNAIDS


OUTLOOK Report 2010
The new UNAIDS Outlook report outlines a radically simplified HIV treatment platform called Treatment 2.0 that could decrease the number of AIDS-related deaths drastically and could also greatly reduce the number of new HIV infections.


UNAIDS Annual Report
Launched in January 1996, the Joint United Nations Programme on HIV/AIDS (UNAIDS) supports and coordinates the efforts of 10 cosponsoring United Nations (UN) system organizations and works with a wide range of other partners in the global response to AIDS.


UNAIDS Fact Sheet
Key facts by region – 2007 AIDS Epidemic Update


UNAIDS and WHO Report: 2009 AIDS Epedmic Update
This report summarizes the latest data on the epidemiology of HIV. The epidemiological estimates in this report reflect continued improvement in national HIV surveillancesystems and estimation methodology


UNAIDS Agenda for Accelerated Country Action for Women, Girls, Gender Equality and HIV
The Agenda for Accelerated Country Action for Women, Girls, Gender Equality and HIV 2010–2014 (Operational Plan) supports the implementation of the UNAIDS Action Framework: Addressing Women, Girls, Gender Equality and HIV1 The Action Framework was developed in response to the pressing need to address the persistent gender inequalities and human rights violations that put women and girls at a greater risk of, and more vulnerable to, HIV and that threaten the gains that have been made in preventing HIV transmission and in increasing access to antiretroviral therapy.


HELPFUL LINKS


Visit the Global Health Council (www.globalhealth.org)


Visit the HIV/AIDS Implementers' meeting (www.hivimplementers.com)


Access the Center for Global Development Publication - "A Risky Business"


Access UNAIDS 2008 Report on the global AIDS epidemic


The Supply Chain Management System (scms) is implemented by the Partnership for Supply Chain Management, Inc. This website was made possible through the support of the President's Emergency Plan for AIDS Relief through the US Agency for International Development (USAID) under the terms of contract no. GPO-I-00-05-00032-00. The views expressed herein do not necessarily reflect those of USAID or the US government.